BNN
COM:BRAIN-BIOTECH
BRAIN Biotech AG
- Stock
Last Close
3.15
25/11 09:24
Market Cap
50.25M
Beta: -
Volume Today
6.57K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '15 | Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 6.82M - | 7.16M 4.93% | 7.61M 6.36% | 7.98M 4.84% | 7.45M 6.70% | 6.99M 6.15% | 8.32M 19.03% | 9.68M 16.32% | ||
average payables | 2.97M - | 2.65M 10.92% | 2.65M 0.19% | 3.65M 37.61% | 3.80M 4.10% | 3.50M 7.86% | 5.29M 51.17% | 6.19M 16.87% | ||
average receivables | 5.12M - | 6.43M 25.51% | 6.74M 4.94% | 6.90M 2.30% | 6.89M 0.18% | 6.76M 1.82% | 9.17M 35.62% | 10.62M 15.85% | ||
book value per share | 0.43 - | 1.76 311.72% | 2.86 62.28% | 1.43 50.16% | 0.68 52.50% | 1.11 64.41% | 1.94 74.57% | 1.36 30.24% | 1.00 26.54% | |
capex per share | -0.05 - | -0.08 74.92% | -0.07 19.62% | -0.08 28.15% | -0.37 338.66% | -0.15 58.31% | -0.06 58.70% | -0.28 339.92% | -0.12 56.63% | |
capex to depreciation | -0.40 - | -0.85 111.02% | -0.64 24.44% | -0.50 21.81% | -1.41 181.00% | -0.66 53.47% | -0.31 52.13% | -1.40 345.73% | -0.57 59.55% | |
capex to operating cash flow | 0.14 - | 0.14 1.50% | 0.19 32.11% | 0.28 49.13% | 1.96 603.16% | 0.60 69.46% | 0.32 46.13% | 4.10 1,167.63% | 0.63 84.73% | |
capex to revenue | -0.03 - | -0.05 92.83% | -0.04 17.19% | -0.06 25.07% | -0.17 207.74% | -0.07 56.55% | -0.03 56.05% | -0.12 273.69% | -0.05 61.19% | |
cash per share | 0.27 - | 1.23 351.07% | 2.37 91.99% | 1.43 39.66% | 0.84 40.99% | 1.02 21.08% | 1.24 21.08% | 0.40 67.39% | 0.25 38.59% | |
days of inventory on hand | 216.52 - | 227.65 5.14% | 231.00 1.47% | 214.64 7.08% | 165.83 22.74% | 149.30 9.96% | 152.15 1.91% | 159.22 4.65% | 140.80 11.57% | |
days payables outstanding | 102.41 - | 91.46 10.69% | 78.18 14.52% | 76.74 1.84% | 92.64 20.72% | 67.98 26.62% | 83.14 22.29% | 111.74 34.40% | 81.32 27.23% | |
days sales outstanding | 74.01 - | 95.37 28.86% | 104.43 9.51% | 88.92 14.86% | 68.22 23.28% | 62.69 8.11% | 66.15 5.52% | 83.91 26.85% | 65.06 22.45% | |
debt to assets | 0.54 - | 0.20 62.09% | 0.14 30.61% | 0.37 163.75% | 0.43 14.98% | 0.42 1.19% | 0.29 31.50% | 0.04 86.60% | 0.42 980.70% | |
debt to equity | 3.00 - | 0.36 87.90% | 0.21 43.42% | 1.08 425.19% | 2.32 114.94% | 1.47 36.54% | 0.58 60.44% | 0.10 82.40% | 1.37 1,238.13% | |
dividend yield | ||||||||||
earnings yield | -0.05 - | -0.08 68.14% | -0.03 64.36% | -0.03 13.24% | -0.05 89.05% | -0.07 40.29% | -0.02 65.87% | -0.07 183.32% | -0.09 35.80% | |
enterprise value | 128.96M - | 178.44M 38.37% | 295.52M 65.61% | 324.73M 9.88% | 229.53M 29.32% | 144.12M 37.21% | 179.52M 24.56% | 90.94M 49.34% | 91.94M 1.10% | |
enterprise value over ebitda | -35.71 - | -13.89 61.09% | -38.94 180.26% | -64.35 65.26% | -41.53 35.47% | -27.74 33.20% | -110.14 296.99% | -20.73 81.18% | -38.04 83.54% | |
ev to operating cash flow | -31.35 - | -20.55 34.46% | -51.33 149.80% | -59.94 16.76% | -67.91 13.30% | -30.23 55.48% | -45.96 52.02% | -61.24 33.24% | -21.80 64.41% | |
ev to sales | 6.10 - | 7.83 28.31% | 12.26 56.58% | 12.00 2.08% | 5.95 50.41% | 3.77 36.66% | 4.68 24.03% | 1.84 60.72% | 1.66 9.55% | |
free cash flow per share | -0.37 - | -0.66 77.24% | -0.41 36.73% | -0.38 7.41% | -0.55 44.52% | -0.41 26.33% | -0.26 36.60% | -0.35 33.66% | -0.31 9.40% | |
free cash flow yield | -0.04 - | -0.06 37.82% | -0.02 62.43% | -0.02 2.13% | -0.05 115.46% | -0.06 24.31% | -0.03 55.43% | -0.08 206.11% | -0.07 5.76% | |
graham net net | -1.16 - | 0.40 134.92% | 1.62 301.03% | -0.50 131.05% | -1.35 169.56% | -0.99 26.53% | -0.13 87.21% | -0.99 676.94% | -1.38 40.13% | |
graham number | 2.08 - | 6.21 198.37% | 6.13 1.31% | 3.84 37.39% | 2.98 22.39% | 3.48 16.92% | 3.20 7.94% | 2.98 7.10% | 2.91 2.07% | |
income quality | 0.69 - | 0.58 15.86% | 0.60 2.41% | 0.65 9.97% | 0.32 50.81% | 0.53 64.15% | 0.83 57.87% | 0.23 71.94% | 0.52 121.97% | |
intangibles to total assets | 0.26 - | 0.16 38.30% | 0.10 36.55% | 0.26 147.62% | 0.24 6.76% | 0.18 22.99% | 0.17 5.37% | 0.21 23.50% | 0.21 0.22% | |
interest coverage | -13.49 - | -84.73 528.18% | -65.55 22.64% | -61.23 6.60% | -24.79 59.52% | -20.58 16.96% | -33.19 61.24% | -27.66 16.64% | -6.39 76.91% | |
interest debt per share | 1.31 - | 0.65 50.36% | 0.60 8.37% | 1.55 159.49% | 1.58 2.31% | 1.66 4.82% | 1.14 31.10% | 0.15 86.86% | 1.41 834.57% | |
inventory turnover | 1.69 - | 1.60 4.89% | 1.58 1.45% | 1.70 7.62% | 2.20 29.44% | 2.44 11.07% | 2.40 1.87% | 2.29 4.44% | 2.59 13.08% | |
invested capital | 3.00 - | 0.36 87.90% | 0.21 43.42% | 1.08 425.19% | 2.32 114.94% | 1.47 36.54% | 0.58 60.44% | 0.10 82.40% | 1.37 1,238.13% | |
market cap | 115.78M - | 177.01M 52.89% | 324.78M 83.48% | 322.48M 0.71% | 216.31M 32.92% | 132.47M 38.76% | 201.42M 52.05% | 96.35M 52.17% | 92.63M 3.85% | |
net current asset value | -9.58M - | 11.42M 219.14% | 32.41M 183.96% | -2.81M 108.67% | -18.07M 543.47% | -12.92M 28.50% | 3.20M 124.79% | -13.36M 516.98% | -22.45M 68.02% | |
net debt to ebitda | -3.65 - | -0.11 96.95% | 3.86 3,564.86% | -0.45 111.60% | -2.39 434.91% | -2.24 6.20% | 13.44 698.97% | 1.23 90.83% | 0.29 76.73% | |
net income per share | -0.45 - | -0.97 116.23% | -0.58 39.98% | -0.46 21.34% | -0.58 26.81% | -0.48 16.85% | -0.23 51.45% | -0.29 23.71% | -0.38 30.56% | |
operating cash flow per share | -0.32 - | -0.57 77.58% | -0.35 39.16% | -0.30 14.07% | -0.19 37.62% | -0.26 36.49% | -0.20 23.34% | -0.07 65.30% | -0.19 184.04% | |
payables turnover | 3.56 - | 3.99 11.96% | 4.67 16.99% | 4.76 1.88% | 3.94 17.16% | 5.37 36.27% | 4.39 18.23% | 3.27 25.60% | 4.49 37.42% | |
receivables turnover | 4.93 - | 3.83 22.39% | 3.49 8.68% | 4.10 17.45% | 5.35 30.34% | 5.82 8.83% | 5.52 5.23% | 4.35 21.17% | 5.61 28.96% | |
research and ddevelopement to revenue | ||||||||||
return on tangible assets | -0.26 - | -0.37 44.62% | -0.16 57.66% | -0.15 4.48% | -0.21 39.56% | -0.15 26.56% | -0.07 52.41% | -0.10 42.11% | -0.15 43.46% | |
revenue per share | 1.66 - | 1.51 9.29% | 1.46 2.94% | 1.50 2.47% | 2.14 42.55% | 2.05 4.07% | 1.92 6.04% | 2.27 17.72% | 2.53 11.77% | |
roe | -1.05 - | -0.55 47.48% | -0.20 63.02% | -0.32 57.81% | -0.86 166.97% | -0.43 49.43% | -0.12 72.19% | -0.21 77.34% | -0.38 77.74% | |
roic | -0.23 - | -0.39 73.30% | -0.17 56.87% | -0.18 7.70% | -0.14 23.76% | -0.14 1.20% | -0.14 2.62% | -0.21 52.06% | -0.11 46.39% | |
sales general and administrative to revenue | 0.05 - | 0.13 171.75% | 0.07 49.02% | 0.08 18.20% | 0.03 55.83% | 0.05 32.36% | 0.04 23.31% | 0.04 21.12% | 0.05 9.42% | |
shareholders equity per share | 0.43 - | 1.76 311.72% | 2.86 62.28% | 1.43 50.16% | 0.68 52.50% | 1.11 64.41% | 1.94 74.57% | 1.36 30.24% | 1.00 26.54% | |
stock based compensation to revenue | ||||||||||
tangible asset value | -2.28M - | 19.18M 941.24% | 40.27M 110.00% | 11.56M 71.29% | 1.30M 88.78% | 12.87M 892.44% | 28.30M 119.83% | 17.48M 38.21% | 7.80M 55.39% | |
tangible book value per share | -0.18 - | 1.27 807.61% | 2.44 92.71% | 0.64 73.79% | 0.07 88.78% | 0.69 860.43% | 1.42 105.66% | 0.80 43.60% | 0.36 55.39% | |
working capital | 7.34M - | 21.59M 193.99% | 45.13M 109.06% | 30.04M 33.43% | 16.08M 46.46% | 20.73M 28.86% | 27.78M 34.03% | 9.00M 67.62% | 8.00M 11.10% |
All numbers in EUR (except ratios and percentages)